Thu, February 16, 2023

Dan Brennan Maintained (TXG) at Buy with Increased Target to $57 on, Feb 16th, 2023

Dan Brennan of Cowen & Co., Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $52 to $57 on, Feb 16th, 2023.

Dan has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Dan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023


This is the rating of the analyst that currently disagrees with Dan


  • Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $50 on, Wednesday, December 14th, 2022